Search results
Results from the WOW.Com Content Network
Peeling skin syndrome 1. Peeling skin syndrome 1 is caused by a genetic defect in the corneodesmosin (CDSN) gene. This gene localizes to the human epidermis and other epithelia. The protein experiences a chain of cleavages during corneocyte maturation. [6] Its symptoms include short stature, abnormality of metabolism/homeostasis, scaling skin ...
Scale forms on the skin surface in various disease settings, and is the result of abnormal desquamation. In pathologic desquamation, such as that seen in X-linked ichthyosis, the stratum corneum becomes thicker (hyperkeratosis), imparting a "dry" or scaly appearance to the skin, and instead of detaching as single cells, corneocytes are shed in clusters, which forms visible scales. [2]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Acral_peeling_skin_syndrome&oldid=954427484"
Ejaculation. Wikimedia Commons has media related to Ejaculation of humans. See also: All pages with titles containing Ejaculation.
Psoriasis. Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by patches of abnormal skin. [ 4][ 5] These areas are red, pink, or purple, dry, itchy, and scaly. [ 8][ 3] Psoriasis varies in severity from small localized patches to complete body coverage. [ 3] Injury to the skin can trigger psoriatic skin changes at that ...
HCMUT is a member of Vietnam National University, Ho Chi Minh City. It focuses on high technology and engineering. It is one of the officially key universities in Vietnam. The predecessor of HCMUT was the National Institute of Technology, established in 1957 by the South Vietnam. [ 2] The institute was renamed National Academy of Technology in ...
Ichthyosis (also named fish scale disease) [ 1] is a family of genetic skin disorders characterized by dry, thickened, scaly skin. [ 2] The more than 20 types of ichthyosis range in severity of symptoms, outward appearance, underlying genetic cause and mode of inheritance (e.g., dominant, recessive, autosomal or X-linked ). [ 3]
Voxelotor was granted accelerated approval by the U.S. Food and Drug Administration (FDA) in November 2019. [12] [11] [15] The FDA granted the application for voxelotor fast track designation and orphan drug designation.